NCT05051579: A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- State
- Completed
- Phase
- Phase 2
- People
- 272 taking part
- Started
- 29 Sep 2021
- Primary completion
- 25 Aug 2022
- Arms
- 12 milligram (mg) LY3502970, 24 mg LY3502970, 36 mg-1 LY3502970, 36 mg-2 LY3502970, 45 mg-1 LY3502970, 45 mg-2 LY3502970
- Results
- Posted on the registry
- 21 Sep 2021: Trial registered
- 29 Sep 2021: Trial started
- 22 Nov 2022: Trial completed
- 13 Sep 2023: Trial results posted